Sub-visible particles pose detection challenge; Elan launches scale-up, manufacturing services;

> Some of the recent drug recalls stemming from particle contamination--one involving sub-visible, 25- to 30-micron particles--highlight inspection and contamination control challenges. Article

> Drug delivery specialist Elan has launched a manufacturing services business encompassing drug product optimization, scale-up, and commercial-scale manufacturing of solid oral dosage forms. Elan release

> Police and health officials in Bangkok, following a tip, raided four drug stockrooms, two of which operate as pharmacies, and found more than 200 varieties of fake pharmaceuticals, unauthorized generics and illegal imports. Article

> Supplier relationship management is as vital an aspect of drug supply chain security technology tools e-pedigree, RFID and spectroscopy. Article

> Contract manufacturer SAFC has completed a 50,000-square-foot expansion of its Jerusalem facility, increasing its capacity to make recombinant proteins and small molecule APIs, including high-potency materials and secondary metabolites. SAFC release

> Bormioli Rocco says it can produce molded glass vials with "optimum glass distribution and an approximate weight reduction of 30% compared to conventional vials." Bormioli Rocco release

> NextPharma has announced the start of construction of a cold chain and logistics warehouse in Werne, Germany. NextPharma release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.